Gut microbiota alterations after switching from a protease inhibitor or efavirenz to raltegravir in a randomized, controlled study

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalAIDS
Volume37
Issue number2
Pages (from-to)323-332
Number of pages10
ISSN0269-9370
DOIs
Publication statusPublished - 1 Feb 2023
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3121 General medicine, internal medicine and other clinical medicine
  • 11832 Microbiology and virology

Cite this